Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG41054

EIF4ENIF1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The EIF4ENIF1 Knockout HEK293T Polyclonal Cells provide a flexible, polyclonal loss-of-function model for studying the EIF4ENIF1 (4E-T) regulatory protein in human cells. Generated via CRISPR/Cas9 editing of the widely used HEK293T host line, this population enables investigation of nucleocytoplasmic eIF4E shuttling, translational repression, and P-body-mediated mRNA decay. EIF4ENIF1 functions downstream of mTOR and stress signaling, interacting with eIF4E, LSM14A, DDX6, PATL1, and AGO2 to control miRNA-dependent silencing. These cells are suited for Western blotting, immunofluorescence, co-IP, RIP, polysome profiling, and reporter assays in cancer biology, neurodevelopment, and translational control research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    EIF4ENIF1

    Gene Identifier

    NCBI Gene ID 56478

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

EIF4ENIF1 Knockout HEK293T Polyclonal Cells are a heterogeneous population of human embryonic kidney cells in which the EIF4ENIF1 gene (encoding 4E-T) has been disrupted by CRISPR/Cas9-mediated gene editing. This polyclonal knockout model, generated by introducing CRISPR components into HEK293T cells, provides a robust loss-of-function system without the genetic uniformity of monoclonal lines. The targeted disruption enables researchers to study the functional consequences of EIF4ENIF1 deficiency in a biologically relevant human cell context, making it suitable for investigations of post-transcriptional gene regulation and related pathways.

The host HEK293T cell line is a derivative of HEK293 cells immortalized with adenovirus type 5 DNA and engineered to express the SV40 large T-antigen. This allows episomal replication of plasmids containing the SV40 origin, facilitating high-level transient protein expression and efficient viral packaging. HEK293T cells are widely adopted for their high transfectability, rapid growth, and ease of use in functional genomics and biochemical studies, providing an optimal background for CRISPR-based knockout models.

EIF4ENIF1 is a nucleocytoplasmic shuttling protein that binds eIF4E and mediates its nuclear import, thereby regulating cap-dependent translation. In the cytoplasm, EIF4ENIF1 localizes to P-bodies and interacts with LSM14A, DDX6, PATL1, and AGO2 to repress translation and promote mRNA decay. It functions downstream of mTOR and stress signaling, integrating these cues into miRNA-mediated gene silencing. Key pathway components include eIF4E, mTOR, 4E-BP, AGO2, and miRNA-induced silencing complexes. Thus, EIF4ENIF1 serves as a central node connecting translational control, mRNA surveillance, and RNA transport.

Knockout of EIF4ENIF1 in HEK293T cells disrupts eIF4E nuclear import and P-body assembly, leading to aberrant translation of normally repressed mRNAs. This model allows dissection of EIF4ENIF1-dependent mechanisms in a clean genetic background without cancer-associated mutations. The high transfectability of HEK293T cells further enables rescue experiments and reporter assays to probe the direct effects of EIF4ENIF1 loss. Consequently, the polyclonal knockout population is ideal for studying the impact on cap-dependent translation, miRNA function, and stress-responsive regulatory networks.

Applications include Western blotting for target validation, immunofluorescence to track eIF4E localization and P-body dynamics, and co-immunoprecipitation to analyze protein interactions. Transcriptome-wide methods such as RIP and polysome profiling can identify translationally regulated mRNAs, while luciferase reporters assess miRNA repression efficiency. These cells are valuable for investigating EIF4ENIF1 roles in cancer, neurodevelopment, and stress responses, as well as for compound screens targeting the eIF4E?C4E-T axis. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)